0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Genome Engineering Editing Market Research Report 2026
Published Date: 2026-04-16
|
Report Code: QYRE-Auto-34Q14901
Home | Market Reports
Global Genome Engineering Editing Market Research Report 2023
BUY CHAPTERS

Global Genome Engineering Editing Market Research Report 2026

Code: QYRE-Auto-34Q14901
Report
2026-04-16
Pages:117
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Genome Engineering Editing Market Size

The global Genome Engineering Editing market was valued at US$ 9754 million in 2025 and is anticipated to reach US$ 31450 million by 2032, at a CAGR of 18.5% from 2026 to 2032.

Genome Engineering Editing Market

Genome Engineering Editing Market

Genome Engineering Editing is a modern molecular biology technology that involves targeted modifications to the genome of an organism to change the sequence of a target gene or regulate its expression. This technology is largely based on genome editing tools such as CRISPR-Cas9, which allows scientists to precisely add, delete or replace an organism's genes.
Global key players of Genome Engineering Editing include Thermo Fisher Scientific, AstraZeneca, SIGMA ALDRICH, Agilent Technologies, Illumina, etc. The top five players hold a share over 52%. North America is the largest market, and has a share about 37%, followed by Asia-Pacific and Europe with share 25% and 18%, separately. In terms of product type, CRISPR RNP is the largest segment, occupied for a share of 39%. In terms of application, GMP has a share about 70 percent.
This report delivers a comprehensive overview of the global Genome Engineering Editing market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Genome Engineering Editing. The Genome Engineering Editing market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Genome Engineering Editing market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Genome Engineering Editing manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Genome Engineering Editing Market Report

Report Metric Details
Report Name Genome Engineering Editing Market
Accounted market size in 2025 US$ 9754 million
Forecasted market size in 2032 US$ 31450 million
CAGR 18.5%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • CRISPR RNP
  • CRISPR mRNA
  • CRISPR Virus Delivery
  • Others
Segment by Application
  • RUO
  • GMP
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Thermo Fisher Scientific, SIGMA ALDRICH, Dharmacon(Horizo​​n Discovery), Cellectics, CRISPR Therapeutics, AstraZeneca, Bio Rad, Allele Biotech, Recombinetics, Lonza, Illumina, Editas Medicine, Agilent Technologies, QIAGEN NV
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Genome Engineering Editing companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Genome Engineering Editing Market growing?

Ans: The Genome Engineering Editing Market witnessing a CAGR of 18.5% during the forecast period 2026-2032.

What is the Genome Engineering Editing Market size in 2032?

Ans: The Genome Engineering Editing Market size in 2032 will be US$ 31450 million.

What is the market share of major companies in Genome Engineering Editing Market?

Ans: The top five players hold a share over 52%.

What is the Genome Engineering Editing Market share by region?

Ans: North America is the largest market, and has a share about 37%, followed by Asia-Pacific and Europe with share 25% and 18%, separately.

What is the Genome Engineering Editing Market share by type?

Ans: In terms of product type, CRISPR RNP is the largest segment, occupied for a share of 39%.

Who are the main players in the Genome Engineering Editing Market report?

Ans: The main players in the Genome Engineering Editing Market are Thermo Fisher Scientific, SIGMA ALDRICH, Dharmacon(Horizo​​n Discovery), Cellectics, CRISPR Therapeutics, AstraZeneca, Bio Rad, Allele Biotech, Recombinetics, Lonza, Illumina, Editas Medicine, Agilent Technologies, QIAGEN NV

What are the Application segmentation covered in the Genome Engineering Editing Market report?

Ans: The Applications covered in the Genome Engineering Editing Market report are RUO, GMP

What are the Type segmentation covered in the Genome Engineering Editing Market report?

Ans: The Types covered in the Genome Engineering Editing Market report are CRISPR RNP, CRISPR mRNA, CRISPR Virus Delivery, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genome Engineering Editing Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 CRISPR RNP
1.2.3 CRISPR mRNA
1.2.4 CRISPR Virus Delivery
1.2.5 Others
1.3 Market by Application
1.3.1 Global Genome Engineering Editing Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 RUO
1.3.3 GMP
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Genome Engineering Editing Market Perspective (2021–2032)
2.2 Global Genome Engineering Editing Growth Trends by Region
2.2.1 Global Genome Engineering Editing Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Genome Engineering Editing Historic Market Size by Region (2021–2026)
2.2.3 Genome Engineering Editing Forecasted Market Size by Region (2027–2032)
2.3 Genome Engineering Editing Market Dynamics
2.3.1 Genome Engineering Editing Industry Trends
2.3.2 Genome Engineering Editing Market Drivers
2.3.3 Genome Engineering Editing Market Challenges
2.3.4 Genome Engineering Editing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Genome Engineering Editing Players by Revenue
3.1.1 Global Top Genome Engineering Editing Players by Revenue (2021–2026)
3.1.2 Global Genome Engineering Editing Revenue Market Share by Players (2021–2026)
3.2 Global Top Genome Engineering Editing Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Genome Engineering Editing Revenue
3.4 Global Genome Engineering Editing Market Concentration Ratio
3.4.1 Global Genome Engineering Editing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genome Engineering Editing Revenue in 2025
3.5 Global Key Players of Genome Engineering Editing Head Offices and Areas Served
3.6 Global Key Players of Genome Engineering Editing, Products and Applications
3.7 Global Key Players of Genome Engineering Editing, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Genome Engineering Editing Breakdown Data by Type
4.1 Global Genome Engineering Editing Historic Market Size by Type (2021–2026)
4.2 Global Genome Engineering Editing Forecasted Market Size by Type (2027–2032)
5 Genome Engineering Editing Breakdown Data by Application
5.1 Global Genome Engineering Editing Historic Market Size by Application (2021–2026)
5.2 Global Genome Engineering Editing Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Genome Engineering Editing Market Size (2021–2032)
6.2 North America Genome Engineering Editing Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Genome Engineering Editing Market Size by Country (2021–2026)
6.4 North America Genome Engineering Editing Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Genome Engineering Editing Market Size (2021–2032)
7.2 Europe Genome Engineering Editing Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Genome Engineering Editing Market Size by Country (2021–2026)
7.4 Europe Genome Engineering Editing Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Genome Engineering Editing Market Size (2021–2032)
8.2 Asia-Pacific Genome Engineering Editing Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Genome Engineering Editing Market Size by Region (2021–2026)
8.4 Asia-Pacific Genome Engineering Editing Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Genome Engineering Editing Market Size (2021–2032)
9.2 Latin America Genome Engineering Editing Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Genome Engineering Editing Market Size by Country (2021–2026)
9.4 Latin America Genome Engineering Editing Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Genome Engineering Editing Market Size (2021–2032)
10.2 Middle East & Africa Genome Engineering Editing Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Genome Engineering Editing Market Size by Country (2021–2026)
10.4 Middle East & Africa Genome Engineering Editing Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Genome Engineering Editing Introduction
11.1.4 Thermo Fisher Scientific Revenue in Genome Engineering Editing Business (2021–2026)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 SIGMA ALDRICH
11.2.1 SIGMA ALDRICH Company Details
11.2.2 SIGMA ALDRICH Business Overview
11.2.3 SIGMA ALDRICH Genome Engineering Editing Introduction
11.2.4 SIGMA ALDRICH Revenue in Genome Engineering Editing Business (2021–2026)
11.2.5 SIGMA ALDRICH Recent Development
11.3 Dharmacon(Horizo​​n Discovery)
11.3.1 Dharmacon(Horizo​​n Discovery) Company Details
11.3.2 Dharmacon(Horizo​​n Discovery) Business Overview
11.3.3 Dharmacon(Horizo​​n Discovery) Genome Engineering Editing Introduction
11.3.4 Dharmacon(Horizo​​n Discovery) Revenue in Genome Engineering Editing Business (2021–2026)
11.3.5 Dharmacon(Horizo​​n Discovery) Recent Development
11.4 Cellectics
11.4.1 Cellectics Company Details
11.4.2 Cellectics Business Overview
11.4.3 Cellectics Genome Engineering Editing Introduction
11.4.4 Cellectics Revenue in Genome Engineering Editing Business (2021–2026)
11.4.5 Cellectics Recent Development
11.5 CRISPR Therapeutics
11.5.1 CRISPR Therapeutics Company Details
11.5.2 CRISPR Therapeutics Business Overview
11.5.3 CRISPR Therapeutics Genome Engineering Editing Introduction
11.5.4 CRISPR Therapeutics Revenue in Genome Engineering Editing Business (2021–2026)
11.5.5 CRISPR Therapeutics Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Genome Engineering Editing Introduction
11.6.4 AstraZeneca Revenue in Genome Engineering Editing Business (2021–2026)
11.6.5 AstraZeneca Recent Development
11.7 Bio Rad
11.7.1 Bio Rad Company Details
11.7.2 Bio Rad Business Overview
11.7.3 Bio Rad Genome Engineering Editing Introduction
11.7.4 Bio Rad Revenue in Genome Engineering Editing Business (2021–2026)
11.7.5 Bio Rad Recent Development
11.8 Allele Biotech
11.8.1 Allele Biotech Company Details
11.8.2 Allele Biotech Business Overview
11.8.3 Allele Biotech Genome Engineering Editing Introduction
11.8.4 Allele Biotech Revenue in Genome Engineering Editing Business (2021–2026)
11.8.5 Allele Biotech Recent Development
11.9 Recombinetics
11.9.1 Recombinetics Company Details
11.9.2 Recombinetics Business Overview
11.9.3 Recombinetics Genome Engineering Editing Introduction
11.9.4 Recombinetics Revenue in Genome Engineering Editing Business (2021–2026)
11.9.5 Recombinetics Recent Development
11.10 Lonza
11.10.1 Lonza Company Details
11.10.2 Lonza Business Overview
11.10.3 Lonza Genome Engineering Editing Introduction
11.10.4 Lonza Revenue in Genome Engineering Editing Business (2021–2026)
11.10.5 Lonza Recent Development
11.11 Illumina
11.11.1 Illumina Company Details
11.11.2 Illumina Business Overview
11.11.3 Illumina Genome Engineering Editing Introduction
11.11.4 Illumina Revenue in Genome Engineering Editing Business (2021–2026)
11.11.5 Illumina Recent Development
11.12 Editas Medicine
11.12.1 Editas Medicine Company Details
11.12.2 Editas Medicine Business Overview
11.12.3 Editas Medicine Genome Engineering Editing Introduction
11.12.4 Editas Medicine Revenue in Genome Engineering Editing Business (2021–2026)
11.12.5 Editas Medicine Recent Development
11.13 Agilent Technologies
11.13.1 Agilent Technologies Company Details
11.13.2 Agilent Technologies Business Overview
11.13.3 Agilent Technologies Genome Engineering Editing Introduction
11.13.4 Agilent Technologies Revenue in Genome Engineering Editing Business (2021–2026)
11.13.5 Agilent Technologies Recent Development
11.14 QIAGEN NV
11.14.1 QIAGEN NV Company Details
11.14.2 QIAGEN NV Business Overview
11.14.3 QIAGEN NV Genome Engineering Editing Introduction
11.14.4 QIAGEN NV Revenue in Genome Engineering Editing Business (2021–2026)
11.14.5 QIAGEN NV Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Genome Engineering Editing Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of CRISPR RNP
 Table 3. Key Players of CRISPR mRNA
 Table 4. Key Players of CRISPR Virus Delivery
 Table 5. Key Players of Others
 Table 6. Global Genome Engineering Editing Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 7. Global Genome Engineering Editing Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 8. Global Genome Engineering Editing Market Size by Region (US$ Million), 2021–2026
 Table 9. Global Genome Engineering Editing Market Share by Region (2021–2026)
 Table 10. Global Genome Engineering Editing Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 11. Global Genome Engineering Editing Market Share by Region (2027–2032)
 Table 12. Genome Engineering Editing Market Trends
 Table 13. Genome Engineering Editing Market Drivers
 Table 14. Genome Engineering Editing Market Challenges
 Table 15. Genome Engineering Editing Market Restraints
 Table 16. Global Genome Engineering Editing Revenue by Players (US$ Million), 2021–2026
 Table 17. Global Genome Engineering Editing Market Share by Players (2021–2026)
 Table 18. Global Top Genome Engineering Editing Players by Tier (Tier 1, Tier 2, and Tier 3), based on Genome Engineering Editing Revenue, 2025
 Table 19. Ranking of Global Top Genome Engineering Editing Companies by Revenue (US$ Million) in 2025
 Table 20. Global 5 Largest Players Market Share by Genome Engineering Editing Revenue (CR5 and HHI), 2021–2026
 Table 21. Global Key Players of Genome Engineering Editing, Headquarters and Area Served
 Table 22. Global Key Players of Genome Engineering Editing, Products and Applications
 Table 23. Global Key Players of Genome Engineering Editing, Date of General Availability (GA)
 Table 24. Mergers and Acquisitions, Expansion Plans
 Table 25. Global Genome Engineering Editing Market Size by Type (US$ Million), 2021–2026
 Table 26. Global Genome Engineering Editing Revenue Market Share by Type (2021–2026)
 Table 27. Global Genome Engineering Editing Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 28. Global Genome Engineering Editing Revenue Market Share by Type (2027–2032)
 Table 29. Global Genome Engineering Editing Market Size by Application (US$ Million), 2021–2026
 Table 30. Global Genome Engineering Editing Revenue Market Share by Application (2021–2026)
 Table 31. Global Genome Engineering Editing Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 32. Global Genome Engineering Editing Revenue Market Share by Application (2027–2032)
 Table 33. North America Genome Engineering Editing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 34. North America Genome Engineering Editing Market Size by Country (US$ Million), 2021–2026
 Table 35. North America Genome Engineering Editing Market Size by Country (US$ Million), 2027–2032
 Table 36. Europe Genome Engineering Editing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 37. Europe Genome Engineering Editing Market Size by Country (US$ Million), 2021–2026
 Table 38. Europe Genome Engineering Editing Market Size by Country (US$ Million), 2027–2032
 Table 39. Asia-Pacific Genome Engineering Editing Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 40. Asia-Pacific Genome Engineering Editing Market Size by Region (US$ Million), 2021–2026
 Table 41. Asia-Pacific Genome Engineering Editing Market Size by Region (US$ Million), 2027–2032
 Table 42. Latin America Genome Engineering Editing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 43. Latin America Genome Engineering Editing Market Size by Country (US$ Million), 2021–2026
 Table 44. Latin America Genome Engineering Editing Market Size by Country (US$ Million), 2027–2032
 Table 45. Middle East & Africa Genome Engineering Editing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 46. Middle East & Africa Genome Engineering Editing Market Size by Country (US$ Million), 2021–2026
 Table 47. Middle East & Africa Genome Engineering Editing Market Size by Country (US$ Million), 2027–2032
 Table 48. Thermo Fisher Scientific Company Details
 Table 49. Thermo Fisher Scientific Business Overview
 Table 50. Thermo Fisher Scientific Genome Engineering Editing Product
 Table 51. Thermo Fisher Scientific Revenue in Genome Engineering Editing Business (US$ Million), 2021–2026
 Table 52. Thermo Fisher Scientific Recent Development
 Table 53. SIGMA ALDRICH Company Details
 Table 54. SIGMA ALDRICH Business Overview
 Table 55. SIGMA ALDRICH Genome Engineering Editing Product
 Table 56. SIGMA ALDRICH Revenue in Genome Engineering Editing Business (US$ Million), 2021–2026
 Table 57. SIGMA ALDRICH Recent Development
 Table 58. Dharmacon(Horizo​​n Discovery) Company Details
 Table 59. Dharmacon(Horizo​​n Discovery) Business Overview
 Table 60. Dharmacon(Horizo​​n Discovery) Genome Engineering Editing Product
 Table 61. Dharmacon(Horizo​​n Discovery) Revenue in Genome Engineering Editing Business (US$ Million), 2021–2026
 Table 62. Dharmacon(Horizo​​n Discovery) Recent Development
 Table 63. Cellectics Company Details
 Table 64. Cellectics Business Overview
 Table 65. Cellectics Genome Engineering Editing Product
 Table 66. Cellectics Revenue in Genome Engineering Editing Business (US$ Million), 2021–2026
 Table 67. Cellectics Recent Development
 Table 68. CRISPR Therapeutics Company Details
 Table 69. CRISPR Therapeutics Business Overview
 Table 70. CRISPR Therapeutics Genome Engineering Editing Product
 Table 71. CRISPR Therapeutics Revenue in Genome Engineering Editing Business (US$ Million), 2021–2026
 Table 72. CRISPR Therapeutics Recent Development
 Table 73. AstraZeneca Company Details
 Table 74. AstraZeneca Business Overview
 Table 75. AstraZeneca Genome Engineering Editing Product
 Table 76. AstraZeneca Revenue in Genome Engineering Editing Business (US$ Million), 2021–2026
 Table 77. AstraZeneca Recent Development
 Table 78. Bio Rad Company Details
 Table 79. Bio Rad Business Overview
 Table 80. Bio Rad Genome Engineering Editing Product
 Table 81. Bio Rad Revenue in Genome Engineering Editing Business (US$ Million), 2021–2026
 Table 82. Bio Rad Recent Development
 Table 83. Allele Biotech Company Details
 Table 84. Allele Biotech Business Overview
 Table 85. Allele Biotech Genome Engineering Editing Product
 Table 86. Allele Biotech Revenue in Genome Engineering Editing Business (US$ Million), 2021–2026
 Table 87. Allele Biotech Recent Development
 Table 88. Recombinetics Company Details
 Table 89. Recombinetics Business Overview
 Table 90. Recombinetics Genome Engineering Editing Product
 Table 91. Recombinetics Revenue in Genome Engineering Editing Business (US$ Million), 2021–2026
 Table 92. Recombinetics Recent Development
 Table 93. Lonza Company Details
 Table 94. Lonza Business Overview
 Table 95. Lonza Genome Engineering Editing Product
 Table 96. Lonza Revenue in Genome Engineering Editing Business (US$ Million), 2021–2026
 Table 97. Lonza Recent Development
 Table 98. Illumina Company Details
 Table 99. Illumina Business Overview
 Table 100. Illumina Genome Engineering Editing Product
 Table 101. Illumina Revenue in Genome Engineering Editing Business (US$ Million), 2021–2026
 Table 102. Illumina Recent Development
 Table 103. Editas Medicine Company Details
 Table 104. Editas Medicine Business Overview
 Table 105. Editas Medicine Genome Engineering Editing Product
 Table 106. Editas Medicine Revenue in Genome Engineering Editing Business (US$ Million), 2021–2026
 Table 107. Editas Medicine Recent Development
 Table 108. Agilent Technologies Company Details
 Table 109. Agilent Technologies Business Overview
 Table 110. Agilent Technologies Genome Engineering Editing Product
 Table 111. Agilent Technologies Revenue in Genome Engineering Editing Business (US$ Million), 2021–2026
 Table 112. Agilent Technologies Recent Development
 Table 113. QIAGEN NV Company Details
 Table 114. QIAGEN NV Business Overview
 Table 115. QIAGEN NV Genome Engineering Editing Product
 Table 116. QIAGEN NV Revenue in Genome Engineering Editing Business (US$ Million), 2021–2026
 Table 117. QIAGEN NV Recent Development
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Genome Engineering Editing Picture
 Figure 2. Global Genome Engineering Editing Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Genome Engineering Editing Market Share by Type: 2025 vs 2032
 Figure 4. CRISPR RNP Features
 Figure 5. CRISPR mRNA Features
 Figure 6. CRISPR Virus Delivery Features
 Figure 7. Others Features
 Figure 8. Global Genome Engineering Editing Market Size by Application (US$ Million), 2021–2032
 Figure 9. Global Genome Engineering Editing Market Share by Application: 2025 vs 2032
 Figure 10. RUO Case Studies
 Figure 11. GMP Case Studies
 Figure 12. Genome Engineering Editing Report Years Considered
 Figure 13. Global Genome Engineering Editing Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 14. Global Genome Engineering Editing Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 15. Global Genome Engineering Editing Market Share by Region: 2025 vs 2032
 Figure 16. Global Genome Engineering Editing Market Share by Players in 2025
 Figure 17. Global Genome Engineering Editing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 18. The Top 10 and 5 Players Market Share by Genome Engineering Editing Revenue in 2025
 Figure 19. North America Genome Engineering Editing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 20. North America Genome Engineering Editing Market Share by Country (2021–2032)
 Figure 21. United States Genome Engineering Editing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. Canada Genome Engineering Editing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Europe Genome Engineering Editing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. Europe Genome Engineering Editing Market Share by Country (2021–2032)
 Figure 25. Germany Genome Engineering Editing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. France Genome Engineering Editing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. U.K. Genome Engineering Editing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Italy Genome Engineering Editing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Russia Genome Engineering Editing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Ireland Genome Engineering Editing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Asia-Pacific Genome Engineering Editing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Asia-Pacific Genome Engineering Editing Market Share by Region (2021–2032)
 Figure 33. China Genome Engineering Editing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Japan Genome Engineering Editing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. South Korea Genome Engineering Editing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Southeast Asia Genome Engineering Editing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. India Genome Engineering Editing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Australia & New Zealand Genome Engineering Editing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Latin America Genome Engineering Editing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Latin America Genome Engineering Editing Market Share by Country (2021–2032)
 Figure 41. Mexico Genome Engineering Editing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Brazil Genome Engineering Editing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Middle East & Africa Genome Engineering Editing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Middle East & Africa Genome Engineering Editing Market Share by Country (2021–2032)
 Figure 45. Israel Genome Engineering Editing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Saudi Arabia Genome Engineering Editing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. UAE Genome Engineering Editing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. Thermo Fisher Scientific Revenue Growth Rate in Genome Engineering Editing Business (2021–2026)
 Figure 49. SIGMA ALDRICH Revenue Growth Rate in Genome Engineering Editing Business (2021–2026)
 Figure 50. Dharmacon(Horizo​​n Discovery) Revenue Growth Rate in Genome Engineering Editing Business (2021–2026)
 Figure 51. Cellectics Revenue Growth Rate in Genome Engineering Editing Business (2021–2026)
 Figure 52. CRISPR Therapeutics Revenue Growth Rate in Genome Engineering Editing Business (2021–2026)
 Figure 53. AstraZeneca Revenue Growth Rate in Genome Engineering Editing Business (2021–2026)
 Figure 54. Bio Rad Revenue Growth Rate in Genome Engineering Editing Business (2021–2026)
 Figure 55. Allele Biotech Revenue Growth Rate in Genome Engineering Editing Business (2021–2026)
 Figure 56. Recombinetics Revenue Growth Rate in Genome Engineering Editing Business (2021–2026)
 Figure 57. Lonza Revenue Growth Rate in Genome Engineering Editing Business (2021–2026)
 Figure 58. Illumina Revenue Growth Rate in Genome Engineering Editing Business (2021–2026)
 Figure 59. Editas Medicine Revenue Growth Rate in Genome Engineering Editing Business (2021–2026)
 Figure 60. Agilent Technologies Revenue Growth Rate in Genome Engineering Editing Business (2021–2026)
 Figure 61. QIAGEN NV Revenue Growth Rate in Genome Engineering Editing Business (2021–2026)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools